Apollomics, Inc. Announces Initiation of SPARTA Phase 2 Clinical Trial for c-MET Inhibitor APL-101

    NEXT STORY
    Global Hospital Cleaning Chemicals Market Forecast to Grow by $ 2.96 Billion during 2020-2024. Progressing at a CAGR of 9%
    PREV STORY
    Apellis Announces Plans to Submit NDA for Pegcetacoplan in Paroxysmal Nocturnal Hemoglobinuria (PNH)
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Genocea Provides Fourth Quarter 2019 Corporate Update

    author_avatar
    NASDAQ Market News

    Roche to launch laboratory SARS-CoV-2 antigen test to support high-volume testing of suspected COVID-19 patients

    author_avatar
    NASDAQ Market News

    Jacksonville University and City of Palm Coast Announce Healthcare Education Campus to Meet Increased Demand for Skilled Healthcare Professionals and Retain Talent in the Region

    author_avatar
    NASDAQ Market News